Literature DB >> 19154550

Identification of B-cell epitopes of Bet v 1 involved in cross-reactivity with food allergens.

E Klinglmayr1, M Hauser, F Zimmermann, O Dissertori, P Lackner, N Wopfner, F Ferreira, M Wallner.   

Abstract

BACKGROUND: The pollen-food syndrome (PFS) is an association of food allergies to fruits, nuts, and vegetables in patients with pollen allergy. Mal d 1, the major apple allergen, is one of the most commonly associated food allergens for birch pollen-allergic patients suffering from PFS. Although the reactions are due to cross-reactive IgE antibodies originally raised against pollen Bet v 1, not every Bet v 1-allergic patient develops clinical reactions towards apple. AIM OF THE STUDY: We speculate that distinct IgE epitopes are responsible for the clinical manifestation of PFS. To test this hypothesis we grafted five Mal d 1 stretches onto Bet v 1. The grafted regions were 7- or 8-amino acids long encompassing amino acids residues previously shown to be crucial for IgE recognition of Bet v 1.
METHODS: A Bet v 1-Mal d 1 chimeric protein designated BMC was expressed in Escherichia coli and purified to homogeneity. IgE reactivity of BMC was tested with patients' sera originating from (i) Bet v 1-allergic patients displaying no clinical symptoms upon ingestion of apples; and (ii) Bet v 1-allergic patients displaying allergic symptoms upon ingestion of apples and other Bet v 1-related foods. RESULTS AND
CONCLUSION: Compared to birch pollen-allergic individuals, patients suffering from PFS showed significantly higher IgE reactivity with BMC (chimeric protein). The results suggest that the Mal d 1 regions grafted onto the Bet v 1 sequence comprise important IgE epitopes recognized by Bet v 1-allergic patients suffering from allergy to apples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154550     DOI: 10.1111/j.1398-9995.2008.01844.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  14 in total

1.  Association Between Food Allergy and Childhood Asthma: So Close and Yet So Far!

Authors:  Joseph L Mathew
Journal:  Indian J Pediatr       Date:  2017-06-23       Impact factor: 1.967

2.  Cross-React: a new structural bioinformatics method for predicting allergen cross-reactivity.

Authors:  Surendra S Negi; Werner Braun
Journal:  Bioinformatics       Date:  2017-04-01       Impact factor: 6.937

3.  An Allergen Portrait Gallery: Representative Structures and an Overview of IgE Binding Surfaces.

Authors:  Catherine H Schein; Ovidiu Ivanciuc; Terumi Midoro-Horiuti; Randall M Goldblum; Werner Braun
Journal:  Bioinform Biol Insights       Date:  2010-10-11

4.  Identification of critical amino acids in the IgE epitopes of Ric c 1 and Ric c 3 and the application of glutamic acid as an IgE blocker.

Authors:  Natalia Deus-de-Oliveira; Shayany P Felix; Camila Carrielo-Gama; Keysson V Fernandes; Renato Augusto DaMatta; Olga L T Machado
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

5.  IgE recognition patterns of profilin, PR-10, and tropomyosin panallergens tested in 3,113 allergic patients by allergen microarray-based technology.

Authors:  Enrico Scala; Claudia Alessandri; Paola Palazzo; Debora Pomponi; Marina Liso; Maria Livia Bernardi; Rosetta Ferrara; Danila Zennaro; Mario Santoro; Chiara Rasi; Adriano Mari
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

6.  Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations.

Authors:  Felix Husslik; Kay-Martin Hanschmann; Ariane Krämer; Christian Seutter von Loetzen; Kristian Schweimer; Iris Bellinghausen; Regina Treudler; Jan C Simon; Lothar Vogel; Elke Völker; Stefanie Randow; Andreas Reuter; Paul Rösch; Stefan Vieths; Thomas Holzhauser; Dirk Schiller
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

7.  Happy 25th birthday, Bet v 1!

Authors:  Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2014-06-03       Impact factor: 4.084

8.  Value of eight-amino-acid matches in predicting the allergenicity status of proteins: an empirical bioinformatic investigation.

Authors:  Rod A Herman; Ping Song; Arvind Thirumalaiswamysekhar
Journal:  Clin Mol Allergy       Date:  2009-10-29

9.  Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study.

Authors:  Margitta Worm; Sabina Rak; Frédéric de Blay; Hans-Jorgen Malling; Michel Melac; Véronique Cadic; Robert K Zeldin
Journal:  Clin Transl Allergy       Date:  2014-02-11       Impact factor: 5.871

10.  Chimeras of Bet v 1 and Api g 1 reveal heterogeneous IgE responses in patients with birch pollen allergy.

Authors:  Barbara Gepp; Nina Lengger; Merima Bublin; Wolfgang Hemmer; Heimo Breiteneder; Christian Radauer
Journal:  J Allergy Clin Immunol       Date:  2014-02-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.